Altasciences

Altasciences is a mid-size contract research organization serving biopharmaceutical companies in Canada and the United States. It provides flexible, end-to-end support for early drug development, working as an extension of clients’ teams to help move promising compounds from preclinical assessment through early clinical trials and toward proof of concept. Its services cover preclinical safety testing for small and large molecules, including in vivo GLP and non-GLP studies; clinical pharmacology trials from first-in-human through Phase II; and bioanalysis from preclinical development through Phase IV.

The company also offers research support for clinical and preclinical studies, plus manufacturing and analytical services, including formulation development, ICH stability testing, and manufacturing from Phase I through commercial scale. Altasciences positions its integrated capabilities as a way to simplify development and support timely decision-making and regulatory submissions. Its resources include scientific publications, case studies, educational content, and information about its facilities and expertise.

The organization emphasizes attentive collaboration, safety, and a personalized approach to advancing drug programs